Search research articles
Contact Us
Filters
Showing results (81-90 of 314) with videos related to
Page
of 32
Sort By:
The Oncologist
|
November 6, 2010
Fatigue in renal cell carcinoma: the hidden burden of current targeted therapies
James M G Larkin, Lynda M Pyle, Martin E Gore
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
January 1, 1996
Transformation of residual mature ovarian teratoma to adenocarcinoma 10 years after initial treatment
F Y Ahmed, M E Gore, J Shepherd, et al.
Cell
|
January 1, 1983
The absence of specific interactions of Sertoli-cell-secreted proteins with antibodies directed against H-Y antigen
R E Gore-Langton, P S Tung, I B Fritz
Family Medicine
|
September 1, 1987
An evaluation of computerized documentation of resident experiences in training
R Schneeweiss, S C Jacobson, D E Montano, et al.
Clinical and Laboratory Haematology
|
February 15, 2000
Delayed haemolytic transfusion reaction caused by anti-M antibody in a patient receiving interleukin-2 and interferon for metastatic renal cell cancer
N Parry-Jones, M E Gore, J Taylor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1995
A matched control study of familial epithelial ovarian cancer: patient characteristics, response to chemotherapy and outcome
J Chang, I Fryatt, B Ponder, et al.
Clinical Radiology
|
October 6, 1997
The significance of paracardiac lymph node enlargement in ovarian cancer
B J Holloway, M E Gore, R P A'Hern, et al.
Frontiers in Psychiatry
|
March 19, 2015
NIDA Clinical Trials Network Common Data Elements Initiative: Advancing Big-Data Addictive-Disorders Research
Udi E Ghitza, Robert E Gore-Langton, Robert Lindblad, et al.
Oncology (Williston Park, N.Y.)
|
May 12, 2001
Clinical trials referral resource. Health related quality of life in cancer clinical trials
E L Trimble, J Rowland, C Varricchio, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
A phase II study of the sequential administration of dacarbazine and fotemustine in the treatment of cerebral metastases from malignant melanoma
J Chang, H Atkinson, R A'Hern, et al.
Page
of 32
Search research articles
Search
Showing results (81-90 of 314) with videos related to
Sort By:
Page
of 32
The Oncologist
|
November 6, 2010
Fatigue in renal cell carcinoma: the hidden burden of current targeted therapies
James M G Larkin, Lynda M Pyle, Martin E Gore
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
January 1, 1996
Transformation of residual mature ovarian teratoma to adenocarcinoma 10 years after initial treatment
F Y Ahmed, M E Gore, J Shepherd, et al.
Cell
|
January 1, 1983
The absence of specific interactions of Sertoli-cell-secreted proteins with antibodies directed against H-Y antigen
R E Gore-Langton, P S Tung, I B Fritz
Family Medicine
|
September 1, 1987
An evaluation of computerized documentation of resident experiences in training
R Schneeweiss, S C Jacobson, D E Montano, et al.
Clinical and Laboratory Haematology
|
February 15, 2000
Delayed haemolytic transfusion reaction caused by anti-M antibody in a patient receiving interleukin-2 and interferon for metastatic renal cell cancer
N Parry-Jones, M E Gore, J Taylor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1995
A matched control study of familial epithelial ovarian cancer: patient characteristics, response to chemotherapy and outcome
J Chang, I Fryatt, B Ponder, et al.
Clinical Radiology
|
October 6, 1997
The significance of paracardiac lymph node enlargement in ovarian cancer
B J Holloway, M E Gore, R P A'Hern, et al.
Frontiers in Psychiatry
|
March 19, 2015
NIDA Clinical Trials Network Common Data Elements Initiative: Advancing Big-Data Addictive-Disorders Research
Udi E Ghitza, Robert E Gore-Langton, Robert Lindblad, et al.
Oncology (Williston Park, N.Y.)
|
May 12, 2001
Clinical trials referral resource. Health related quality of life in cancer clinical trials
E L Trimble, J Rowland, C Varricchio, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
A phase II study of the sequential administration of dacarbazine and fotemustine in the treatment of cerebral metastases from malignant melanoma
J Chang, H Atkinson, R A'Hern, et al.
Page
of 32